1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Burlington, New Jersey. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Burlington.
Burlington, New Jersey has 1 SAMHSA-verified addiction treatment center offering 1 dual diagnosis, 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Burlington residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Burlington accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Burlington sits within New Jersey's broader addiction-treatment infrastructure — a network of licensed providers ranging from medically supervised detox facilities through residential treatment, partial hospitalization, intensive outpatient, and standard outpatient counseling. Patients seeking care in Burlington have access to options at multiple intensity levels, with placement decisions driven by ASAM criteria: withdrawal risk, biomedical conditions, emotional/behavioral status, readiness to change, relapse potential, and the patient's current recovery environment. The specific providers verified for Burlington below represent facilities that have been confirmed against SAMHSA's treatment-locator database and New Jersey licensing records.
Family involvement in Burlington program admission typically begins with the admissions call itself — many patients seeking treatment have a family member or partner initiating the contact. Most facilities allow family conversations during the admission process (subject to 42 CFR Part 2 confidentiality), schedule family education or therapy sessions early in treatment, and explicitly involve family in discharge planning. Family-system engagement correlates with better treatment outcomes across the literature.
Insurance coverage for addiction treatment in Burlington is governed by the Mental Health Parity and Addiction Equity Act (MHPAEA), which requires plans that cover substance-use treatment to do so at parity with medical/surgical benefits. In practice: if your plan covers a hospitalization for a heart condition, it must cover residential addiction treatment under comparable cost-sharing, day limits, and authorization requirements. The ACA further classifies substance-use disorder treatment as an Essential Health Benefit, meaning individual and small-group marketplace plans must include this coverage.
PTSD intersects with substance use in many Burlington treatment-seeking patients, particularly those with combat history, sexual assault history, childhood trauma, or intimate-partner violence exposure. Trauma-informed treatment programs screen routinely for trauma history, train clinical staff in trauma-informed practice, avoid re-traumatization in program structure, and offer evidence-based trauma-focused therapies including EMDR, prolonged exposure, and cognitive processing therapy — modalities developed and validated largely through VA-funded PTSD research.
Employment re-entry after addiction treatment is a Burlington priority that intersects with long-term recovery sustainability. The Americans with Disabilities Act protects employees in recovery from discrimination based on past substance use (current illegal use is not protected). FMLA may apply to treatment-related absences. State vocational rehabilitation services offer career counseling, education funding, and job placement support. Recovery-friendly employer initiatives are emerging in many U.S. markets including New Jersey.
Family members of Burlington patients in active addiction can access support through Al-Anon, Nar-Anon, SMART Recovery Family & Friends, and Community Reinforcement and Family Training (CRAFT). CRAFT specifically teaches evidence-based techniques for engaging a reluctant family member into treatment — research shows approximately 70% of CRAFT participants successfully engage their loved one into treatment within 3-6 months, substantially higher than traditional intervention approaches.
Detox alone — withdrawal management without subsequent treatment — produces poor outcomes across substance categories, with relapse rates approaching 80% in studies of opioid detox-only protocols. Burlington providers typically integrate detox into a longer treatment episode: detox transitions seamlessly into residential or intensive outpatient care, with same-clinical-team continuity, rather than discharging patients post-detox without structured next-step care. This continuity is the single most impactful predictor of post-treatment success.